# Study of EB-001 in Facial Scar Reduction

> **NCT03346902** · PHASE2 · COMPLETED · sponsor: **Bonti, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Mohs Surgery

## Interventions

- **DRUG:** EB-001
- **DRUG:** 0.9% Sodium Chloride Injection

## Key facts

- **NCT ID:** NCT03346902
- **Lead sponsor:** Bonti, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-06
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-10-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03346902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03346902, "Study of EB-001 in Facial Scar Reduction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03346902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*